Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

EMA image

EMA ponders biosimilar guideline

May 14, 2013 Research and Development, Sales and Marketing EMA, biosimilars

The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …
News
Lilly image

Lilly takes $30m hit

May 13, 2013 Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …
News

John LaMattina: India’s solution to drug costs

May 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …
Feature

New Board member for Misonix

May 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Misonix

Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …
Appointment
Takeda image

Takeda to buy Inviragen

May 10, 2013 Research and Development, Sales and Marketing Inviragen, Takeda

Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …
News
stan_musial

Egalet appoints Stan Musial as CFO

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Egalet, musial

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer.  Bob Radie, president and chief …
Appointment
danai_brooks

Dyadic International hires chief operating officer

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing dyadic

Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer.  Starting in …
Appointment
ABPI image

VBP will be ‘unfair’: report

May 8, 2013 Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
News
astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013 Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …
News

Funding boost for GSK open lab

May 7, 2013 Research and Development, Sales and Marketing GSK, Wellcome

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …
News
Buffet image

Lessons from the business gurus

May 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …
Feature
28569_guenter_100

Sanofi appoints two executive members

May 3, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …
Appointment
Boehringer image

Boehringer and OBT in cancer tie-up

May 2, 2013 Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …
News
EMA image

Court rules against EMA disclosure

May 2, 2013 Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …
News

GSK abandons Parkinson’s drug

May 1, 2013 Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026